Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Andersson, Patrik Edén, D. Lindgren, Jens Nilsson, C. Lassen, J. Heldrup, M. Fontes, Å. Borg, F. Mitelman, B. Johansson, M. Höglund, T. Fioretos (2005)
Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrationsLeukemia, 19
H. Dekken, E. Geelen, W. Dinjens, B. Wijnhoven, H. Tilanus, H. Tanke, C. Rosenberg (1999)
Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.Cancer research, 59 3
C. Buskens, M. Westerterp, S. Lagarde, J. Bergman, F. Kate, J. Lanschot (2004)
Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features.Gastrointestinal endoscopy, 60 5
M. Barrett, C. Sanchez, L. Prevo, D. Wong, P. Galipeau, T. Paulson, P. Rabinovitch, B. Reid (1999)
Evolution of neoplastic cell lineages in Barrett oesophagusNature Genetics, 22
T. Kim, H. Jong, Sang-Hyun Song, Alexandre Dimtchev, Sook-Jung Jeong, Jung Lee, Tae-You Kim, N. Kim, M. Jung, Y. Bang (2003)
Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cellsOncogene, 22
Catherine Gleeson, J. Sloan, J. Mcguigan, A. Ritchie, J. Weber, S. Russell (1998)
Barrett's oesophagus: Microsatellite analysis provides evidence to support the proposed metaplasia‐dysplasia‐carcinoma sequenceGenes, 21
S. Yang, M. Seo, H. Jeong, H. Jeung, Jihye Shin, S. Kim, S. Noh, H. Chung, S. Rha (2005)
Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients.Clinical cancer research : an official journal of the American Association for Cancer Research, 11 2 Pt 1
K. Nakayama, H. Akiyama, F. Hanyu, R. Nakayama (2006)
Guide lines for the clinical and pathologic studies on carcinoma of the esophagusThe Japanese journal of surgery, 6
G. Zaninotto, A. Parenti, A. Ruol, M. Costantini, S. Merigliano, E. Ancona (2000)
Oesophageal resection for high‐grade dysplasia in Barrett's oesophagusBritish Journal of Surgery, 87
M Menke-Pluymers, N Schoute, A. Mulder, W Hop, M. Blankenstein, H. Tilanus (1992)
Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus.Gut, 33
P. Riegman, K. Vissers, J. Alers, E. Geelen, W. Hop, H. Tilanus, H. Dekken (2001)
Genomic alterations in malignant transformation of Barrett's esophagus.Cancer research, 61 7
Jeng-Kai Jiang, Yann-Jang Chen, Chi-Hung Lin, I. Yu, Jen‐Kou Lin (2005)
Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases—An analysis by comparative genomic hybridizationGenes, 43
M. Pera, V. Trastek, H. Carpenter, M. Allen, C. Deschamps, P. Pairolero (1992)
Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy?The Annals of thoracic surgery, 54 2
P. Wild, A. Herr, C. Wissmann, R. Stoehr, A. Rosenthal, D. Zaak, R. Simon, R. Knuechel, C. Pilarsky, A. Hartmann (2005)
Gene Expression Profiling of Progressive Papillary Noninvasive Carcinomas of the Urinary BladderClinical Cancer Research, 11
Charles Miller, Justin Moy, Lin Lin, M. Schipper, D. Normolle, D. Brenner, M. Iannettoni, M. Orringer, D. Beer (2003)
Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade dysplasia.Clinical cancer research : an official journal of the American Association for Cancer Research, 9 13
Chun‐Ming Wong, J. Lee, Y. Ching, D. Jin, I. Ng (2003)
Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma.Cancer research, 63 22
M Bruno (2003)
Magnification endoscopy, high resolution endoscopy, and chromoscopy; towards a better optical diagnosisGut, 52
H. Dekken, J. Alers, P. Riegman, C. Rosenberg, H. Tilanus, K. Vissers (2001)
Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions.The American journal of pathology, 158 6
Bao-Zhu Yuan, A. Jefferson, Kimberly Baldwin, S. Thorgeirsson, N. Popescu, S. Reynolds (2004)
DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomasOncogene, 23
T. Wu, Toshiaki Watanabe, R. Heitmiller, Marianna Zahurak, A. Forastiere, S. Hamilton (1998)
Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region.The American journal of pathology, 153 1
A. Cassoni (1987)
Tnm Classification of Malignant Tumours
M. Westerterp, L. Koppert, C. Buskens, H. Tilanus, F. Kate, J. Bergman, P. Siersema, H. Dekken, J. Lanschot (2005)
Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junctionVirchows Archiv, 446
H. Lee, Seung-Sook Lee, Sun Lee, H. Um (2003)
Bcl-w is expressed in a majority of infiltrative gastric adenocarcinomas and suppresses the cancer cell death by blocking stress-activated protein kinase/c-Jun NH2-terminal kinase activation.Cancer research, 63 5
B. Zaharieva, R. Simon, P. Diener, D. Ackermann, R. Maurer, G. Alund, H. Knönagel, M. Rist, K. Wilber, F. Hering, A. Schönenberger, R. Flury, Peter Jäger, J. Fehr, M. Mihatsch, T. Gasser, G. Sauter, D. Toncheva (2003)
High‐throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancerThe Journal of Pathology, 201
S. Tsuji, R. Hosotani, S. Yonehara, T. Masui, Sidhartha Tulachan, S. Nakajima, Hiroyuki Kobayashi, M. Koizumi, E. Toyoda, D. Ito, K. Kami, Tomohiko Mori, K. Fujimoto, R. Doi, M. Imamura (2003)
Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinomaInternational Journal of Cancer, 106
P. Paris, Armann Andaya, J. Fridlyand, Ajay Jain, V. Weinberg, D. Kowbel, John Brebner, J. Simko, J. Watson, S. Volik, D. Albertson, D. Pinkel, J. Alers, T. Kwast, K. Vissers, F. Schrōder, M. Wildhagen, P. Febbo, A. Chinnaiyan, K. Pienta, P. Carroll, M. Rubin, C. Collins, H. Dekken (2005)
Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors.Human molecular genetics, 13 13
María González, M. Artímez, L. Rodrigo, C. López-Larrea, M. Menéndez, V. Álvarez, R. Pérez, M. Fresno, M. Perez, A. Sampedro, E. Coto (1997)
Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma.Journal of Clinical Pathology, 50
T. Rice, E. Blackstone, J. Goldblum, M. Decamp, S. Murthy, G. Falk, A. Ormsby, L. Rybicki, J. Richter, D. Adelstein (2001)
Superficial adenocarcinoma of the esophagus.The Journal of thoracic and cardiovascular surgery, 122 6
P. Froelicher, G. Miller (1986)
The European experience with esophageal cancer limited to the mucosa and submucosa.Gastrointestinal endoscopy, 32 2
P. Galipeau, L. Prevo, C. Sanchez, G. Longton, B. Reid (2000)
Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.Journal of the National Cancer Institute, 91 24
A. Walch, H. Zitzelsberger, J. Bruch, G. Keller, D. Angermeier, M. Aubele, James Mueller, H. Stein, H. Braselmann, J. Siewert, H. Höfler, M. Werner (2000)
Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence.The American journal of pathology, 156 2
N. Fukushima, N. Sato, N. Prasad, S. Leach, R. Hruban, M. Goggins (2004)
Characterization of gene expression in mucinous cystic neoplasms of the pancreas using oligonucleotide microarraysOncogene, 23
Z. Zhuang, A. Vortmeyer, E. Mark, R. Odze, M. Emmert-Buck, Maria Merino, Hanlim Moon, L. Liotta, P. Duray (1996)
Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma.Cancer research, 56 9
Q. Han, Jay Leng, D. Bian, C. Mahanivong, K. Carpenter, Z. Pan, Jiahuai Han, Shuang Huang (2002)
Rac1-MKK3-p38-MAPKAPK2 Pathway Promotes Urokinase Plasminogen Activator mRNA Stability in Invasive Breast Cancer Cells*The Journal of Biological Chemistry, 277
K. Takubo, K. Sasajima, K. Yamashita, Yoichi Tanaka, K. Fujita (1991)
Double muscularis mucosae in Barrett's esophagus.Human pathology, 22 11
J. Dolina, A. Hep, P. Dítě, H. Munzova, M. Kunovská, L. Husova, F. Vlckova, Z. Pilottova (2000)
[Barrett's esophagus].Bratislavske lekarske listy, 101 6
A. Hölscher, E. Bollschweiler, P. Schneider, J. Siewert (1995)
Prognosis of early esophageal cancer. Comparison between adeno‐and squamous cell carcinomaCancer, 76
Amy Tai, Wen-sheng Yan, Yan Fang, D. Xie, J. Sham, X. Guan (2004)
Recurrent chromosomal imbalances in nonsmall cell lung carcinomaCancer, 100
S. Gratias, A. Schüler, L. Hitpass, H. Stephan, H. Rieder, Stephanie Schneider, B. Horsthemke, D. Lohmann (2005)
Genomic gains on chromosome 1q in retinoblastoma: Consequences on gene expression and association with clinical manifestationInternational Journal of Cancer, 116
K. Dolan, J. Garde, J. Gosney, M. Sissons, T. Wright, A. Kingsnorth, S. Walker, R. Sutton, SJ Meltzer, J. Field (1998)
Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites.British Journal of Cancer, 78
Yongliang Zhu, Xian Zhong, Shu Zheng, Zhen Ge, Q. Du, Suzhan Zhang (2005)
Transformation of immortalized colorectal crypt cells by microcystin involving constitutive activation of Akt and MAPK cascade.Carcinogenesis, 26 7
M. Hage, P. Siersema, H. Dekken, E. Steyerberg, J. Haringsma, W. Vrie, T. Grool, R. Veen, H. Sterenborg, E. Kuipers (2004)
5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s oesophagus: a randomised trialGut, 53
J. Knijnenburg, K. Szuhai, J. Giltay, L. Molenaar, W. Sloos, M. Poot, H. Tanke, C. Rosenberg (2005)
Insights from genomic microarrays into structural chromosome rearrangementsAmerican Journal of Medical Genetics Part A, 132A
H. Fiegler, P. Carr, Eleanor Douglas, D. Burford, S. Hunt, James Smith, D. Vetrie, P. Gorman, I. Tomlinson, N. Carter (2003)
DNA microarrays for comparative genomic hybridization based on DOP‐PCR amplification of BAC and PAC clonesGenes, 36
L. Qin, Zhao-You Tang, J. Sham, Zeng-chen Ma, S. Ye, Xin-da Zhou, Zhi-quan Wu, J. Trent, X. Guan (1999)
The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma.Cancer research, 59 22
Prateek Sharma (2002)
Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus.Gastrointestinal endoscopy, 55 1
C. Rosenberg, E. Geelen, M. Ijszenga, P. Pearson, H. Tanke, W. Dinjens, H. Dekken (2002)
Spectrum of genetic changes in gastro-esophageal cancer cell lines determined by an integrated molecular cytogenetic approach.Cancer genetics and cytogenetics, 135 1
M. Barrett, P. Galipeau, C. Sanchez, M. Emond, B. Reid (1996)
Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms.Oncogene, 12 9
Ohanna, W., Van, Andick, Ngela, M. G.E., De, Iebo, W. J, ten, Ate (2002)
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma the esophagus
Early (T1 stage) adenocarcinoma of the esophagus or gastroesophageal junction is a potentially curable disease. We analyzed the genomic spectra of 33 early neoplastic lesions after subdividing the tumors into six depths of invasion (T1–mucosal, m1–m3; T1–submucosal, sm1–sm3). Two subgroups were defined, T1m1–sm1 (n = 18) and T1sm2–sm3 (n = 15). The latter group is associated with frequent lymphatic spread and a high percentage of local and/or distant recurrence. Comparative genomic hybridization with a genomewide 3,500‐element BAC‐PAC array revealed a characteristic gastroesophageal adenocarcinoma pattern of changes, with losses on chromosome arms 4pq, 5q, 8p, 9p, 17p, and 18q and gains on 1q, 6p, 7pq, 11q, 15q, 17q, and 20pq. However, when the two groups were compared, the following BAC clones showed significantly more alterations in the T1sm2–sm3 group: RP11‐534L20 (1q32.1) and RP11‐175A4 (6p21.32), showing gains, and RP11‐356F24, RP11‐433L7, and RP11‐241P12 (all at 8p), showing losses. Gain of RP11‐534L20 (1q32.1) and loss of RP11‐433L7 (8p22) were associated not only with a recurrence‐free period (P = 0.0007 and 0.007, respectively), but also with regional lymphatic dissemination (P = 0.005 and 0.003, respectively). These DNA clones can be considered genomic markers for the aggressive behavior of early esophageal and gastroesophageal junction adenocarcinoma. © 2006 Wiley‐Liss, Inc.
Genes, Chromosomes and Cancer – Wiley
Published: May 1, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.